The core cerebrospinal fluid (CSF) biomarkers for AD pathophysiology are amyloid-β peptides (Aβ40 and Aβ42), total-tau (t-tau), and phosphorylated tau (p-tau), which are believed to have the highest diagnostic accuracy for early AD diagnosis [22,23]. This evidence concerns the gene MAPT and Alzheimer disease.